Shaping the future of non-invasive diagnostics with artificial intelligence.
Fibronostics is a global US-based healthcare technology company focusing on non-invasive algorithm-based solutions for diagnostic testing. Founded in 2017, Fibronostics comprises of a team of physicians, data scientists, and life science experts driven to improve healthcare with technology.
Fibronostics algorithm-based solutions focus on assessing liver disease existence and progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea.
The LiverFASt and HealthFACTR family of tests quickly and accurately analyze blood biomarker data with digital results, providing rapid and inexpensive early alerts well before a patient’s condition demands the expense and risk of invasive procedures.
Let's work together
We’re ready to lead you in to the future of healthcare.
If you want to know more about our products and services or have questions, we’d love to hear from you.
3F Makati Stock Exchange Building
6767 Ayala Avenue, Makati City 1226